A REPORT released this morning
warns than more than 3,500 often
fatal and “entirely unnecessary”
strokes will be suffered by
Australians with an irregular
heartbeat this year.
The Deloitte Access Economics
study, commissioned by Pradaxa
maker Boehringer Ingelheim and
developed in conjunction with the
Baker IDI Heart & Diabetes
Institute, shows that almost 25% of
first-ever strokes in 2011 will be
caused by atrial fibrillation - not
adequately treated by the common
therapies of warfarin and aspirin.
At least half of these could be
avoided with the use of effective
stroke prevention medicines, the
report claims, as well as
recommending an atrial fibrillation
awareness campaign and encouraging
GPs to routinely check patients
over 50 for irregular heartbeats.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Sep 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Sep 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.